{"title":"Treatment of Attention-Deficit/Hyperactivity Disorder With Stimulants: Reducing Harms.","authors":"Leslie Arceneaux, Intima Alrimawi, Karan Kverno","doi":"10.3928/02793695-20250212-02","DOIUrl":null,"url":null,"abstract":"<p><p>An increase in attention-deficit/hyperactivity disorder (ADHD) diagnoses since 2020, along with shortages in prescription stimulants and an increase in overdose deaths from stimulants, has triggered alarm within the public sector, regulatory agencies, and health care systems. Stimulants are classified as Schedule II drugs by the Drug Enforcement Administration due to the potential for misuse and physiological and psychological dependence. Despite concerns, stimulants are effective first-line treatments for children and adults with ADHD. The majority of deaths related to stimulants are linked to misuse of illicitly manufactured stimulants that may contain the synthetic opioid, fentanyl. The current article provides a brief overview of the problem, along with clinical strategies for preventing and reducing harm. [<i>Journal of Psychosocial Nursing and Mental Health Services, 63</i>(3), 7-10.].</p>","PeriodicalId":50071,"journal":{"name":"Journal of Psychosocial Nursing and Mental Health Services","volume":"63 3","pages":"7-10"},"PeriodicalIF":1.2000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Psychosocial Nursing and Mental Health Services","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3928/02793695-20250212-02","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"NURSING","Score":null,"Total":0}
引用次数: 0
Abstract
An increase in attention-deficit/hyperactivity disorder (ADHD) diagnoses since 2020, along with shortages in prescription stimulants and an increase in overdose deaths from stimulants, has triggered alarm within the public sector, regulatory agencies, and health care systems. Stimulants are classified as Schedule II drugs by the Drug Enforcement Administration due to the potential for misuse and physiological and psychological dependence. Despite concerns, stimulants are effective first-line treatments for children and adults with ADHD. The majority of deaths related to stimulants are linked to misuse of illicitly manufactured stimulants that may contain the synthetic opioid, fentanyl. The current article provides a brief overview of the problem, along with clinical strategies for preventing and reducing harm. [Journal of Psychosocial Nursing and Mental Health Services, 63(3), 7-10.].
期刊介绍：
The Journal of Psychosocial Nursing and Mental Health Services is a peer-reviewed, monthly journal for psychosocial and mental health nurses in a variety of community and institutional settings. For more than 50 years, the Journal has provided the most up-to-date, practical information available for today’s psychosocial-mental health nurse, including short contributions about psychopharmacology, mental health care of older adults, addictive behaviors and diagnoses, and child/adolescent disorders and issues. Begin to explore the Journal and all of its great benefits such as:
• Monthly feature, “Clip & Save: Drug Chart,” a one-page resource of up-to-date information on current medications for various psychiatric illnesses
• Access to current articles, as well as several years of archived content
• Articles posted online just 2 months after acceptance
• Continuing Nursing Education credits available each month
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
